Related Experiment Video
Updated: Jul 4, 2026
05:46
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
Published on: May 27, 2022
Urease inhibitor from Datisca cannabina linn
Mansoor Ahmad1, Noor Muhammad, Manzoor Ahmad
1Institute of Pharmaceutical Sciences, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan. herbalist51@yahoo.com
Journal of Enzyme Inhibition and Medicinal Chemistry
|June 24, 2008
Summary
A novel flavonoid, datisdirin, was isolated from D. cannabina Linn. This compound demonstrated significant activity against the urease enzyme, suggesting potential therapeutic applications.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Enzymology
Background:
- D. cannabina Linn. is a plant source of bioactive compounds.
- Flavonoids are a class of natural products with diverse biological activities.
- Urease enzymes are implicated in various pathological conditions.
Purpose of the Study:
- To isolate and characterize compounds from D. cannabina Linn.
- To evaluate the urease inhibitory activity of isolated compounds.
- To identify novel urease inhibitors from natural sources.
Main Methods:
- Extraction of ethyl acetate fraction from D. cannabina Linn.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation of new compounds via spectral data analysis (e.g., NMR, MS).
- In vitro assay to determine urease inhibitory activity.
Main Results:
- A new flavonoid, datisdirin (1), was isolated and structurally identified.
- Eight known compounds were also isolated: tectochrysine, cearoin, sideroxyline, ursolic acid, corosolic acid, arjunolic acid, erythrodiol, and oleanolic acid.
- Datisdirin exhibited notable activity against the urease enzyme.
Conclusions:
- Datisdirin is a novel flavonoid with potential urease inhibitory properties.
- D. cannabina Linn. is a promising source for discovering new bioactive molecules.
- Further research into datisdirin could lead to the development of new urease-targeting therapeutics.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.